|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 5.860 USD | -2.01% |
|
-2.33% | -4.87% |
| 10-05 | Lifevantage Corporation Approves A Change in Fiscal Year End from June 30 to December 31 | CI |
| 09-20 | LifeVantage Corporation(NasdaqCM:LFVN) dropped from S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIFEVANTAGE CORPORATION | Other Pharmaceuticals | -2.01% | -2.33% | -4.87% | -33.56% | -13.82% | 73.41M |  |  | |
- Stock Market
- Stocks
- LFVN Stock
- Charts LifeVantage Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
